This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (62)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Konrad Bork, MD; Sven-Erik Barnstedt, MD

Arch Intern Med. 2001;161:714-718.

Background  Hereditary angioedema (HAE) is an autosomal dominant disease (Mendelian Inheritance in Man 106100) caused by an inherited deficiency of C1 inhibitor (C1-INH) function. The clinical symptoms include skin swelling, abdominal pain, and life-threatening episodes of upper airway obstruction. We evaluated the efficacy of C1-INH concentrate for treating sudden airway compromise.

Methods  A series of 95 patients with HAE and a functional deficiency of C1-INH belonging to 59 families underwent screening for laryngeal edema. Double-blind treatment of randomized patients was not justifiable because of the life-threatening nature of this condition. Efficacy was evaluated by determining the interval from injection of C1-INH concentrate to the beginning of resolution of symptoms. The mean duration of episodes of laryngeal edema was compared in treated and untreated patients. Clinical information was obtained from emergency department physicians, the hospitals involved, reports of the general practitioners, and patients and their relatives.

Results  Forty-two patients had 517 episodes of laryngeal edema. Eighteen patients received 500- or 1000-U injections of C1-INH concentrate in 193 episodes. The C1-INH concentrate was effective in all laryngeal edemas. The interval from injection to interruption in progress of symptoms ranged from 10 minutes to 4 hours (mean ± SD, 42.2 ± 19.9 minutes). The mean ± SD duration of laryngeal edema was 15.3 ± 9.3 hours in patients who received C1-INH concentrate and 100.8 ± 26.2 hours in those who did not.

Conclusions  Injected C1-INH concentrate is highly and rapidly effective in the treatment of laryngeal edema of HAE. Relief and resolution of symptoms begins 30 to 60 minutes after injection, and duration of the upper airway obstruction is substantially reduced.

From the Department of Dermatology, University of Mainz, Mainz, Germany.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hereditary Angioedema
Zuraw
NEJM 2008;359:1027-1036.
FULL TEXT  

Hereditary angioedema and pregnancy: A successful outcome using C1 esterase inhibitor concentrate
Gorman
cfp 2008;54:365-366.
FULL TEXT  

Management of Hereditary Angioedema in Pediatric Patients
Farkas et al.
Pediatrics 2007;120:e713-e722.
ABSTRACT | FULL TEXT  

Genetic Test Indications and Interpretations in Patients With Hereditary Angioedema
Weiler and Van Dellen
Mayo Clin Proc. 2006;81:958-972.
ABSTRACT | FULL TEXT  

The Powerful Neuroprotective Action of C1-Inhibitor on Brain Ischemia-Reperfusion Injury Does Not Require C1q
De Simoni et al.
Am. J. Pathol. 2004;164:1857-1863.
ABSTRACT | FULL TEXT  

Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema
BORK and BARNSTEDT
Journal of the American Dental Association 2003;134:1088-1094.
ABSTRACT | FULL TEXT  

Clinical Studies of Sudden Upper Airway Obstruction in Patients With Hereditary Angioedema Due to C1 Esterase Inhibitor Deficiency
Bork et al.
Arch Intern Med 2003;163:1229-1235.
ABSTRACT | FULL TEXT  

Treatment of 193 Episodes of Laryngeal Edema with C1 Inhibitor Concentrate in Patients with Hereditary Angioedema
Adinoff
Pediatrics 2002;110:438-438.
FULL TEXT